Palatin Technologies Inc (PTN) stock
PTNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$5.36−0.76 (-12.49%)
Close on Nov 17, 2026Market cap $9.55MP/E –Yield –
Palatin Technologies r&d expenses
Research and development expenses are spending on new products and technology.
Palatin Technologies's R&D Expenses for the twelve months ending Jun 30, 2026 was $12.37M, down 17.0% year over year. For fiscal 2026 it was $12.37M, down 17.0% from the year before. Over ten years it grew -11.7% a year on average. The highest annual figure on record is $43.07M in fiscal 2016.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $12.37M | -17.0% |
| FY2025 | Jun 30, 2025 | $14.90M | -33.5% |
| FY2024 | Jun 30, 2024 | $22.40M | -1.0% |
| FY2023 | Jun 30, 2023 | $22.63M | +6.1% |
| FY2022 | Jun 30, 2022 | $21.33M | +65.0% |
| FY2021 | Jun 30, 2021 | $12.93M | -7.4% |
| FY2020 | Jun 30, 2020 | $13.96M | -6.0% |
| FY2019 | Jun 30, 2019 | $14.86M | -54.4% |
| FY2018 | Jun 30, 2018 | $32.57M | 0.0% |
| FY2017 | Jun 30, 2017 | $32.57M | -24.4% |
| FY2016 | Jun 30, 2016 | $43.07M | +75.4% |
| FY2015 | Jun 30, 2015 | $24.56M | +126.8% |
| FY2014 | Jun 30, 2014 | $10.83M | +2.8% |
| FY2013 | Jun 30, 2013 | $10.53M | -23.8% |
| FY2012 | Jun 30, 2012 | $13.81M | +33.1% |
| FY2011 | Jun 30, 2011 | $10.38M | -15.6% |
| FY2010 | Jun 30, 2010 | $12.29M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $2.01M | +1.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $3.52M | -6.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $4.32M | +26.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $2.53M | -56.0% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.97M | -57.8% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $3.76M | -49.3% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $3.43M | -29.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $5.74M | -22.8% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $4.67M | -6.2% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $7.41M | +36.5% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $4.83M | +38.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $7.44M | +113.6% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $4.98M | +98.4% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $5.43M | +35.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $3.48M | +19.2% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $3.48M | -11.5% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $2.51M | -31.1% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $4.01M | +23.1% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $2.92M | -6.5% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $3.93M | -9.1% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $3.64M | -7.7% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $3.26M | +10.0% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $3.13M | -13.7% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $4.33M | -18.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $3.94M | -44.2% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $2.96M | -51.0% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $3.62M | -74.4% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $5.29M | +27.6% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $7.07M | -22.0% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $6.05M | -25.7% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $14.16M | +26.2% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $4.14M | -60.6% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $9.06M | -15.1% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $8.13M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $11.23M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $10.52M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $10.68M | – |
See a number that looks wrong?